Appropriate use of Cardiac Resynchronization Therapy in Europe

25 August 2018 (09:54 - 10:12)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Professor Christophe Leclercq

Hospital Pontchaillou of Rennes, Rennes (France)

4 More presentations in this session

Presentation thumbnail

Can Data Registries be used to Evaluate Quality? A US Perspective

Professor F. Masoudi (St Louis, US)

Presentation thumbnail

Quality metrics and their influence on interventional cardiology: Focus on the European experience

Doctor P. Kearney (Cork, IE)

Presentation thumbnail

Assessing quality of care in heart failure: What are the right Metrics?

Doctor M. Walsh (Indianapolis, US)

Presentation thumbnail

Panel Discussion: Quality Metrics in Cardiology - Are we trying to measure the immeasureable?

Access the full session

Session thumbnail

The Influence of Quality Metrics in Interventional Cardiology and Heart Failure: Helpful or Hopeless?

The Event

ESC Congress 2018

25 August 2018 09:54 CET

You may be interested in

Webinar

New 2021 HF guidelines - what is new for device therapies and how to optimally combine new HF drugs with ICD-CRTDs

16 February 2023

Congress Presentation

Real-life experience in cardiac resynchronization: evaluation of the clinical impact and echocardiographic variables of cardiac function in patients with conduction disorders beyond left bundle branch

29 June 2021

Congress Presentation

Improving outcomes at reduced costs; the implementation of a cardiac resynchronization therapy care pathway

29 June 2021

Congress Presentation

Cardiac resynchronization therapy practice who gets it and why? A comparison between ESC HF registry, CRT Survey II and SwedeHF.

23 May 2022

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources